FSD Pharma Wins Court Judgment Against Former CEO, Dr. Raza Bokhari
Portfolio Pulse from Benzinga Newsdesk
FSD Pharma Inc. (NASDAQ:HUGE) won a court judgment against its former CEO, Dr. Raza Bokhari, for over USD $147,301.04 and CAD $2,861,141.70 plus interest. The judgment was confirmed by the United States District Court for the Eastern District of Pennsylvania, following an arbitration ruling in favor of FSD Pharma.
June 28, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
FSD Pharma Inc. (NASDAQ:HUGE) secured a favorable court judgment against its former CEO, Dr. Raza Bokhari, for significant monetary damages. This legal victory could positively impact investor sentiment and the company's stock price in the short term.
The court judgment in favor of FSD Pharma against its former CEO for substantial monetary damages is a significant legal victory. This outcome is likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100